P1923Edoxaban vs warfarin in vitamin K antagonist experienced and naive patients from the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomized trial
Autor: | Kurt Huber, M Merino, Søren Pihlkjær Hjortshøj, A. Cohen, Assen Goudev, James Jin, Andreas Goette, Shannon M Winters, Naab Al-Saady, G Y H Lip |
---|---|
Rok vydání: | 2018 |
Předmět: |
medicine.medical_specialty
medicine.drug_class business.industry medicine.medical_treatment Warfarin Atrial fibrillation Vitamin K antagonist Cardioversion medicine.disease law.invention Therapy naive chemistry.chemical_compound chemistry Randomized controlled trial Edoxaban law Internal medicine medicine Cardiology Cardiology and Cardiovascular Medicine business medicine.drug |
Zdroj: | European Heart Journal. 39 |
ISSN: | 1522-9645 0195-668X |
DOI: | 10.1093/eurheartj/ehy565.p1923 |
Databáze: | OpenAIRE |
Externí odkaz: |